Free tool
FAERS Monitor: Norepinephrine Bitartrate In 0.9% Sodium Chloride
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 214628 or its brand name (Norepinephrine Bitartrate In 0.9% Sodium Chloride, Norepinephrine Bitartrate). Reports on generic versions are filed under their own applications.
Reports
13,464
Serious
12,974
96% of reports
Hospitalization
7,221
Death reported
4,381
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective2,961
- off label use1,391
- hypotension1,343
- acute kidney injury929
- multiple organ dysfunction syndrome891
- condition aggravated868
- sepsis740
- toxicity to various agents737
- cardiac arrest684
- cardiogenic shock683
- septic shock591
- respiratory failure514
- shock469
- death463
- renal failure448
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 64 |
| 2005 | 71 |
| 2006 | 90 |
| 2007 | 91 |
| 2008 | 79 |
| 2009 | 90 |
| 2010 | 120 |
| 2011 | 233 |
| 2012 | 161 |
| 2013 | 109 |
| 2014 | 187 |
| 2015 | 244 |
| 2016 | 358 |
| 2017 | 462 |
| 2018 | 491 |
| 2019 | 575 |
| 2020 | 1,384 |
| 2021 | 1,508 |
| 2022 | 1,422 |
| 2023 | 1,590 |
| 2024 | 1,549 |
| 2025 | 1,573 |
| 2026 | 1,012 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,695 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| cardiogenic shockSignal | 683 | 78.0 | 72.4 | 49,416 |
| multiple organ dysfunction syndromeSignal | 891 | 50.7 | 47.5 | 42,053 |
| shockSignal | 469 | 32.5 | 29.7 | 14,008 |
| septic shockSignal | 591 | 21.5 | 19.9 | 11,398 |
| cardiac arrestSignal | 684 | 13.0 | 12.1 | 7,560 |
| respiratory failureSignal | 514 | 11.1 | 10.2 | 4,687 |
| hypotensionSignal | 1,343 | 10.5 | 10.0 | 11,597 |
| sepsisSignal | 740 | 10.4 | 9.7 | 6,289 |
| acute kidney injurySignal | 929 | 9.5 | 9.0 | 7,098 |
| toxicity to various agentsSignal | 737 | 6.9 | 6.4 | 3,692 |
| renal failureSignal | 448 | 5.3 | 4.8 | 1,557 |
| condition aggravatedSignal | 868 | 4.5 | 4.2 | 2,362 |
| drug ineffectiveSignal | 2,961 | 3.5 | 3.4 | 5,670 |
| off label useSignal | 1,391 | 2.5 | 2.4 | 1,283 |
| death | 463 | 0.8 | 0.8 | 15 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.